Cargando…
High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587123/ https://www.ncbi.nlm.nih.gov/pubmed/32848041 http://dx.doi.org/10.1128/JCM.01352-20 |
| _version_ | 1783600123595456512 |
|---|---|
| author | Boukli, Narjis Le Mene, Melchior Schnuriger, Aurélie Cuervo, Nancy Stella Laroche, Cécilia Morand-Joubert, Laurence Gozlan, Joël |
| author_facet | Boukli, Narjis Le Mene, Melchior Schnuriger, Aurélie Cuervo, Nancy Stella Laroche, Cécilia Morand-Joubert, Laurence Gozlan, Joël |
| author_sort | Boukli, Narjis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7587123 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Society for Microbiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75871232020-11-06 High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies Boukli, Narjis Le Mene, Melchior Schnuriger, Aurélie Cuervo, Nancy Stella Laroche, Cécilia Morand-Joubert, Laurence Gozlan, Joël J Clin Microbiol Letter to the Editor American Society for Microbiology 2020-10-21 /pmc/articles/PMC7587123/ /pubmed/32848041 http://dx.doi.org/10.1128/JCM.01352-20 Text en Copyright © 2020 American Society for Microbiology. All Rights Reserved (https://doi.org/10.1128/ASMCopyrightv2) . https://doi.org/10.1128/ASMCopyrightv2 This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Boukli, Narjis Le Mene, Melchior Schnuriger, Aurélie Cuervo, Nancy Stella Laroche, Cécilia Morand-Joubert, Laurence Gozlan, Joël High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies |
| title | High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies |
| title_full | High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies |
| title_fullStr | High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies |
| title_full_unstemmed | High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies |
| title_short | High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies |
| title_sort | high incidence of false-positive results in patients with acute infections other than covid-19 by the liaison sars-cov-2 commercial chemiluminescent microparticle immunoassay for detection of igg anti-sars-cov-2 antibodies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587123/ https://www.ncbi.nlm.nih.gov/pubmed/32848041 http://dx.doi.org/10.1128/JCM.01352-20 |
| work_keys_str_mv | AT bouklinarjis highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies AT lemenemelchior highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies AT schnurigeraurelie highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies AT cuervonancystella highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies AT larochececilia highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies AT morandjoubertlaurence highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies AT gozlanjoel highincidenceoffalsepositiveresultsinpatientswithacuteinfectionsotherthancovid19bytheliaisonsarscov2commercialchemiluminescentmicroparticleimmunoassayfordetectionofiggantisarscov2antibodies |